#25. L. John Doerr Buys $19.3M of AMYRIS, INC. latest buy: 04/15/2019
During the last six months, Doerr bet big on AMRS:
L. John Doerr
Amyris is an industrial biotechnology company that is applies its technology platform to engineer, manufacture and sell products into the Health and Wellness, Clean Skincare, and Flavors and Fragrances markets. Co.'s technology platform allows Co. to engineer microbes and to metabolize renewable, plant-sourced sugars into ingredients. Co. has focused its development activities primarily on the production of Biofene®, its brand of renewable farnesene, a branched hydrocarbon molecule that manufactures through fermentation using engineered microbes. Co.'s farnesene derivatives are sold in various products including nutraceuticals, skin care, fragrances, solvents, and lubricants ingredients.
AMRS — Key Stats (updated Friday, April 19, 10:21 AM)
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.